Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $83,082 - $98,956
-681 Reduced 2.72%
24,319 $3.15 Million
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $1.15 Million - $1.38 Million
-9,398 Reduced 27.32%
25,000 $3.1 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $3.27 Million - $3.92 Million
24,398 Added 243.98%
34,398 $5.03 Million
Q4 2022

Feb 14, 2023

SELL
$129.72 - $159.85 $3.11 Million - $3.84 Million
-24,000 Reduced 70.59%
10,000 $1.59 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $763,211 - $971,754
6,029 Added 21.55%
34,000 $4.53 Million
Q2 2022

Aug 15, 2022

BUY
$141.59 - $168.66 $1.28 Million - $1.53 Million
9,065 Added 47.95%
27,971 $4.36 Million
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $2.45 Million - $3.04 Million
18,906 New
18,906 $2.94 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.